Application of four pricing models for orphan medicines: a case study for lumasiran
Abstract Background The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks might be necessary to support reimbursement negotiations. In this stud...
Saved in:
| Main Authors: | Noa Rosenberg, Evert Manders, Sibren van den Berg, Lisa J. Deesker, Sander F. Garrelfs, Saco J. de Visser, Jaap W. Groothoff, Carla E. M. Hollak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-024-03446-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SOCIO-CULTURAL ADAPTATION OF CHILDREN-ORPHANS BY LITERATURE
by: N. Yushkina
Published: (2018-03-01) -
Analysing criteria for price and reimbursement of orphan drugs in Spain
by: Xavier Badia, et al.
Published: (2019-07-01) -
Physical activity and quality of life in adolescents and orphans
by: Lucija Maglica, et al.
Published: (2020-06-01) -
Environmental Impacts of Orphaned and Abandoned Wells: Methane Emissions, and Implications for Carbon Storage
by: Ahmed Alsubaih, et al.
Published: (2024-12-01) -
Late onset primary hyperoxaluria after kidney transplantation in a 36-year-old woman
by: Amirhesam Alirezaei, et al.
Published: (2024-05-01)